Publications

HRA Pharma has collaborated on a number of scientific publications in the areas of women’s health and endocrinology – whether through scientific cooperation or sponsorship.

filter by theme
Women's health
Endocrinology
Academic support
Non clinical
 contact us

Publications

HRA Pharma has collaborated on a number of scientific publications in the areas of women’s health and endocrinology – whether through scientific cooperation or sponsorship.

Nallasamy S, Kim J, Sitruk-Ware R, Bagchi M, Bagchi I. Ulipristal blocks ovulation by inhibiting progesterone receptor-dependent pathways intrinsic to the ovary.
Reprod Sci 2013 Apr; 20:371-381
Palinasamy GS, Cheon Y-P, Kim J, et al. A novel pathway involving progesterone receptor, endothelin-2, and endothelin receptor B controls ovulation in mice. Mol
Endocrinol 2006; 20: 2784-2795
Pohl O, Williams AR, Bergeron C, Gotteland JP. A 39-week oral toxicity study of ulipristal acetate in cynomolgus monkeys.
Regul Toxicol Pharmacol. 2013 a;66:6-12
Pohl O, Harvey PW, McKeag S, Boley SE, Gotteland JP. Carcinogenicity and chronic rodent toxicity of the selective progesterone receptor modulator ulipristal acetate.
Curr Drug Saf. 2013 b; 8:77-97.
Busiah K, Drunat S, Vaivre-Douret L,et al. Neuropsychological dysfunction and neurodevelopmental defects associated with genetic changes in infants with neonatal diabetes mellitus: a prospective cohort study.
Lancet Diabetes Endocrinol. 2013 ; 3:199-207
Bonnefond A, Lomberk G, Buttar N, Busiah K, et al. Disruption of a novel Kruppel-like transcription factor p300-regulated pathway for insulin biosynthesis revealed by studies of the c.-331 INS mutation found in neonatal diabetes mellitus.
J Biol Chem. 2011; 286:28414-24
Liposomal polychemotherapy improves adrenocortical carcinoma treatment in a preclinical rodent model.
Hantel C, Jung S, Mussack T, Reincke M, Beuschlein F. Endocr Relat Cancer. 2014 Feb 14.
Comparison of two mitotane starting dose regimens in patients with advanced adrenocortical carcinoma.
Kerkhofs TM, Baudin E, Terzolo M, Allolio B, Chadarevian R, Mueller HH, Skogseid B, Leboulleux S, Mantero F, Haak HR, Fassnacht M. J Clin Endocrinol Metab. 2013 Dec;98(12):4759-67.
closeyou are leaving hra pharma
You are now leaving www.hra-pharma.com and being redirected to an external website which might not be under control of HRA Pharma.
do you want to proceed ?